SOURCE: Titan Medical Inc.

Titan Medical Inc.

November 19, 2015 16:18 ET

Titan Medical Inc. Completes First Successful Surgical Cadaver Studies Using the SPORT™ Surgical System

TORONTO, ON--(Marketwired - November 19, 2015) - Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQX: TITXF) today announced that it has completed its first successful cadaver lab studies with the SPORT Surgical System. Procedures performed included total abdominal hysterectomy, prostatectomy, and ureteroneocystostomy, addressing three key anatomical areas of focus for SPORT. The cadaver studies were performed by two experienced robotic surgeons from the Company's Surgeon Advisory Board.

Dr. Dennis Fowler, Titan Medical Inc.'s Executive Vice President, Clinical and Regulatory Affairs, stated, "Both surgeons, as well as our engineering team, were quite pleased with the performance of the SPORTSurgical System. With these studies, we have documented that surgeons can successfully complete all of the tasks required to perform very complex procedures."

John Hargrove, Chairman and CEO of Titan Medical Inc., commented, "We are thrilled to have successfully completed our first cadaver studies. The positive procedure outcomes and compelling surgeon feedback give us confidence in SPORT's significant value proposition to patients and hospitals as we move forward through our commercialization process."

About Titan Medical Inc.

Titan Medical Inc. is a Canadian public company focused on the design and development of a robotic surgical system for application in minimally invasive surgery ("MIS"). The Company's Single Port Orifice Robotic Technology, SPORT™ Surgical System, currently under development, is comprised of a surgeon-controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient's body during MIS procedures. The SPORT™ Surgical System is being designed to expand robotic surgery into both simple and complex areas of surgical specialties and procedures that are currently under-serviced. It is also being designed to allow surgeons to perform procedures within small- to medium-size surgical spaces for general abdominal, gynecologic, and urologic indications. For more information, visit the Company's website at

Forward-Looking Statements

This news release contains "forward-looking statements" which reflect the current expectations of management of the Company's future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors " section of the Company's Annual Information Form dated March 31, 2015 (which may be viewed at Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.

Contact Information